Photo by nci from unsplash
Alloantibodies to the low‐frequency antigen Scianna‐2 (Sc2) have been implicated in cases of hemolytic disease of the fetus and newborn but never in hemolytic transfusion reactions (HTRs); thus, the clinical… Click to show full abstract
Alloantibodies to the low‐frequency antigen Scianna‐2 (Sc2) have been implicated in cases of hemolytic disease of the fetus and newborn but never in hemolytic transfusion reactions (HTRs); thus, the clinical significance of anti‐Sc2 has yet to be fully addressed.
Keywords:
anti sc2;
sc2;
hemolytic transfusion;
first case;
transfusion;
case severe
Journal Title: Transfusion
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Transfusion
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!